Latest Lanthanum carbonate Stories

2012-07-20 12:16:47

Longest placebo-controlled trial of phosphate binders conducted to date challenges the drugs' utility Highlights: -Phosphate binders, drugs commonly prescribed to patients with chronic kidney disease, may not be as effective as previously thought. -Phosphate binders may have negative effects on cardiovascular health. -Additional studies are needed on the safety and effectiveness of these drugs. Drugs commonly prescribed to patients with chronic kidney disease (CKD) may not be as...

2009-10-28 03:00:00

DUBLIN, October 28 /PRNewswire-FirstCall/ -- - FOSRENOL(R) (lanthanum carbonate) Now Approved in the EU to Treat hyperphosphataemia >1.78mmol/L in Chronic Kidney Disease Patients Not on Dialysis Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the...

2009-10-07 02:42:00

DUBLIN, October 7 /PRNewswire-FirstCall/ -- - For Medical and Healthcare Media Only - - Direct Comparison of the Two non-Calcium Phosphate Binders Gives new Insights Into Relative Efficacy Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate)...

2009-02-09 06:00:00

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), announces that it has received Paragraph IV Notice letters from Barr Laboratories, Inc. ("Barr) and Mylan, Inc. ("Mylan) dated 2 and 4 February 2009 respectively, advising in each case of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of 500mg, 750mg and 1gm FOSRENOL(R), (lanthanum carbonate). FOSRENOL is protected by three FDA...

2008-06-22 15:00:27

A New York doctor's sloppy penmanship put a patient's health at risk when he was given the incorrect medication for several months, a lawsuit contends. Jeffrey Deutchman, 55, of New York, allegedly received lithium carbonate, a medication typically used to treat manic depression, when he was supposed to get lanthanum carbonate for his kidney failure, court documents indicate. Dr. Heino Anto of Peninsula Hospital Center is accused of illegibly writing Deutchman's prescription in March...

2008-04-03 12:01:03

PHILADELPHIA, April 3, 2008 /PRNewswire/ -- Shire Pharmaceuticals, the global biopharmaceutical company, today announced the launch of On Track, an innovative program designed to improve adherence to disease management regimens among chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (elevated levels of phosphorus in the blood). In addition to offering the highly effective phosphate binder, FOSRENOL (lanthanum carbonate), Shire has created On Track, a program designed to...

Word of the Day
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.